Natalizumab (Tysabri?) is usually a leukocytes chemotaxis inhibitor that decreases the leukocytes passage through the hematoencephalic barrier and it is currently used in relapsing-remitting forms of multiple sclerosis (MS). tomography scan exhibited pulmonary infiltrates. The bronchoscopy with the bronchoalveolar lavage resulted in eosinophilic alveolitis. No evidence of bacterial fungal and parasitic contamination connective tissue disease… Continue reading Natalizumab (Tysabri?) is usually a leukocytes chemotaxis inhibitor that decreases the